Analysts Offer Insights on Healthcare Companies: Accuray (NASDAQ: ARAY), Evolus (NASDAQ: EOLS) and Caris Life Sciences, Inc. (NASDAQ: CAI)↓ Price Target: Accuray, Inc. (ARAY, Buy, $5 → $4 PT; Mkt Cap $172M) – ‘we reiterate our Buy rating and trim our PT from $5 to $4’